A liposomal drug platform overrides peptide ligand targeting to a cancer biomarker, irrespective of ligand affinity or density (Q27308658)
Jump to navigation
Jump to search
scientific article (publication date: 2013)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A liposomal drug platform overrides peptide ligand targeting to a cancer biomarker, irrespective of ligand affinity or density |
scientific article (publication date: 2013) |
Statements
A liposomal drug platform overrides peptide ligand targeting to a cancer biomarker, irrespective of ligand affinity or density (English)
0 references
2013
0 references
8
0 references
8
0 references
e72938
0 references
23 August 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference